Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemocoagulase Atrox (Baquting) for perioperative hemostasis in elective craniotomy for meningioma and glioma
ChiCTR-TRC-11001322Phase 4Completed
- Sponsor
- China Nuokang Bio-Pharmaceutical
- Start
- Mar 2011
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of batroxobin in meningioma and glioma (3 arms), sponsored by China Nuokang Bio-Pharmaceutical. Primary endpoint: Intraoperative hemorrhage volume. Started Mar 2011; status: completed.
02
Drugs
batroxobin
03
Conditions
meningiomaglioma
Beyond the preview
Go deeper on ChiCTR-TRC-11001322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001322.